KRONOX LAB SCIENCES LIMITED (KRONOX.BO)
- Previous Close
137.35 - Open
135.00 - Bid 135.70 x --
- Ask 136.30 x --
- Day's Range
135.00 - 137.60 - 52 Week Range
133.65 - 228.55 - Volume
2,189 - Avg. Volume
13,818 - Market Cap (intraday)
5.084B - Beta (5Y Monthly) --
- PE Ratio (TTM)
28.12 - EPS (TTM)
4.85 - Earnings Date --
- Forward Dividend & Yield 0.50 (0.36%)
- Ex-Dividend Date Aug 23, 2024
- 1y Target Est
--
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents, such as ACS reagents, and LR, AR and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, including tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specification, and specialty anhydrous. The company was incorporated in 2008 and is based in Vadodara, India.
www.kronoxlabsciences.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: KRONOX.BO
View MorePerformance Overview: KRONOX.BO
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KRONOX.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KRONOX.BO
View MoreValuation Measures
Market Cap
5.12B
Enterprise Value
4.98B
Trailing P/E
28.32
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.72
Price/Book (mrq)
6.61
Enterprise Value/Revenue
5.59
Enterprise Value/EBITDA
19.56
Financial Highlights
Profitability and Income Statement
Profit Margin
26.01%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
962.39M
Net Income Avi to Common (ttm)
250.34M
Diluted EPS (ttm)
4.85
Balance Sheet and Cash Flow
Total Cash (mrq)
193.92M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--